Abstract
Background. Inflammatory bowel disease (IBD) predisposes to colorectal cancer
(CRC) with some specific features that distinguish it from sporadic CRC. Magnesium
(Mg) homeostasis is severely compromised in IBD patients, which may affect both
inflammation and tumor development. Efficient transcellular Mg transport in intestinal
cells depends on the transient receptor potential melastatin (TRPM) channels type 6
and 7, but their expression has never been investigated in the context of IBD-related
CRC.
Aims. We sought to study the expression pattern of TRPM6 and TRPM7 in CRC, and
to compare IBD-related cases to sporadic cases.
Methods. TRPM6 and TRPM7 protein expression was evaluated by
immunohistochemistry in surgical specimens from 16 IBD and 13 NON-IBD CRC
patients.
Results. TRPM7 expression was higher in tumor tissue than in the adjacent nonneoplastic
tissue in both IBD and NON-IBD patients. Overall, adenocarcinomas
showed higher TRPM7 expression than adenomas. TRPM7 expression also
positively correlated with tumor grade. Conversely, TRPM6 expression was higher in
tumor tissues in both IBD and NON-IBD CRC, but it did not correlate with tumor stage
or grade.
Conclusions. We report possible participation of TRPM6 and 7 in both IBD-related
and sporadic CRC and suggest that TRPM7 might serve as a marker of malignant
transformation and lack of differentiation.
Lingua originale | English |
---|---|
pagine (da-a) | 1188-1194 |
Rivista | Digestive and Liver Disease |
Volume | 52 |
DOI | |
Stato di pubblicazione | Pubblicato - 2020 |
Keywords
- TRPM6
- biomarker
- colorectal cancer
- inflammatory bowel disease
- magnesium
- personalized medicine
- sporadic